# Flowserve Corp: overview

FLS · NYSE · CIK 30625 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fls.md) · [Financials](/companies/fls/financials.md) · [Filings](/companies/fls/filings.md) · [Insiders](/companies/fls/insiders.md)

Latest reported revenue: [$1.24bn](/filings/0000030625-26-000026.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 28, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000030625-26-000026).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,180 d](/filings/0000030625-26-000003.md) | [1,145](/filings/0000030625-26-000012.md) | [1,188](/filings/0000030625-26-000020.md) | [1,174](/filings/0000030625-26-000026.md) | [1,222 d](/filings/0000030625-26-000003.md) | [1,068](/filings/0000030625-26-000012.md) | [1,169](/filings/0000030625-26-000020.md) | [1,238](/filings/0000030625-26-000026.md) |
| Gross margin | % | [31.5% d](/filings/0000030625-26-000003.md) | [32.3%](/filings/0000030625-26-000012.md) | [34.2%](/filings/0000030625-26-000020.md) | [32.4%](/filings/0000030625-26-000026.md) | [34.8% d](/filings/0000030625-26-000003.md) | [35.6%](/filings/0000030625-26-000012.md) | [32.9%](/filings/0000030625-26-000020.md) | [33.5%](/filings/0000030625-26-000026.md) |
| Operating margin | % | [10.6% d](/filings/0000030625-26-000003.md) | [11.5%](/filings/0000030625-26-000012.md) | [12.3%](/filings/0000030625-26-000020.md) | [6.7%](/filings/0000030625-26-000026.md) | [3.5% d](/filings/0000030625-26-000003.md) | [11.2%](/filings/0000030625-26-000012.md) | [13.0%](/filings/0000030625-26-000020.md) | [12.5%](/filings/0000030625-26-000026.md) |
| Net margin | % | [6.6% d](/filings/0000030625-26-000003.md) | [6.5%](/filings/0000030625-26-000012.md) | [6.9%](/filings/0000030625-26-000020.md) | [18.7%](/filings/0000030625-26-000026.md) | [(2.4%) d](/filings/0000030625-26-000003.md) | [7.6%](/filings/0000030625-26-000012.md) | [8.5%](/filings/0000030625-26-000020.md) | [8.3%](/filings/0000030625-26-000026.md) |
| Diluted EPS | $ per share | not reported | [0.56](/filings/0000030625-26-000012.md) | [0.62](/filings/0000030625-26-000020.md) | [1.67](/filings/0000030625-26-000026.md) | not reported | [0.64](/filings/0000030625-26-000012.md) | [0.77](/filings/0000030625-26-000020.md) | [0.81](/filings/0000030625-26-000026.md) |
| Free cash flow | $m | [168 d](/filings/0000030625-26-000003.md) | [(61.7)](/filings/0000030625-26-000012.md) | [138 d](/filings/0000030625-26-000020.md) | [385 d](/filings/0000030625-26-000026.md) | [(25.6) d](/filings/0000030625-26-000003.md) | [(60.0)](/filings/0000030625-26-000012.md) | [112 d](/filings/0000030625-26-000020.md) | [127 d](/filings/0000030625-26-000026.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,541](/filings/0000030625-24-000025.md) | [3,615](/filings/0000030625-25-000039.md) | [4,321](/filings/0000030625-26-000003.md) | [4,558](/filings/0000030625-26-000003.md) | [4,729](/filings/0000030625-26-000003.md) |
| Gross margin | % | [29.6%](/filings/0000030625-24-000025.md) | [27.5%](/filings/0000030625-25-000039.md) | [29.6%](/filings/0000030625-26-000003.md) | [31.5%](/filings/0000030625-26-000003.md) | [33.4%](/filings/0000030625-26-000003.md) |
| Operating margin | % | [7.6%](/filings/0000030625-24-000025.md) | [5.5%](/filings/0000030625-25-000039.md) | [7.7%](/filings/0000030625-26-000003.md) | [10.1%](/filings/0000030625-26-000003.md) | [8.5%](/filings/0000030625-26-000003.md) |
| Net margin | % | [3.6%](/filings/0000030625-24-000025.md) | [5.2%](/filings/0000030625-25-000039.md) | [4.3%](/filings/0000030625-26-000003.md) | [6.2%](/filings/0000030625-26-000003.md) | [7.3%](/filings/0000030625-26-000003.md) |
| Diluted EPS | $ per share | [0.96](/filings/0000030625-24-000025.md) | [1.44](/filings/0000030625-25-000039.md) | [1.42](/filings/0000030625-26-000003.md) | [2.14](/filings/0000030625-26-000003.md) | [2.64](/filings/0000030625-26-000003.md) |
| Free cash flow | $m | [195](/filings/0000030625-24-000025.md) | [(116)](/filings/0000030625-25-000039.md) | [258](/filings/0000030625-26-000003.md) | [344](/filings/0000030625-26-000003.md) | [435](/filings/0000030625-26-000003.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fls/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $999.6m | 13,479,378 |  | Added +306,447 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $462.0m | 6,230,091 |  | Added +38,203 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $427.6m | 5,766,004 |  | Added +62,077 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $419.0m | 5,649,681 |  | Added +854,342 |
| [D1 Capital Partners L.P.](/funds/1747057.md) | 2026-06-30 | $368.5m | 4,968,713 |  | Reduced −905,728 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $310.4m | 4,173,333 |  | Added +47,328 |
| [FIL Ltd](/funds/318989.md) | 2026-06-30 | $308.7m | 4,163,193 |  | New +4,163,193 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $253.0m | 3,411,142 |  | Added +421,044 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $251.8m | 3,394,740 |  | Added +667,269 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $226.8m | 3,024,862 |  | Reduced −621,571 |

## Recent filings

[All 1,577 filings](/companies/fls/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 16:20 ET | [10-Q](/filings/0000030625-26-000026.md) | Quarterly report, period 2026-09-30 | 0000030625-26-000026 |
| 2026-10-28 | 16:18 ET | [8-K](/filings/0001193125-26-436189.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436189 |
| 2026-09-14 | 07:00 ET | [8-K](/filings/0001193125-26-389817.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-389817 |
| 2026-08-05 | 16:15 ET | [8-K](/filings/0001628280-26-053369.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-053369 |
| 2026-07-29 | 16:05 ET | [8-K](/filings/0001193125-26-323649.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-323649 |
| 2026-07-29 | 16:01 ET | [10-Q](/filings/0000030625-26-000020.md) | Quarterly report, period 2026-06-30 | 0000030625-26-000020 |
| 2026-06-30 | 16:12 ET | [8-K](/filings/0001628280-26-046231.md) | 7.01 Regulation FD disclosure | 0001628280-26-046231 |
| 2026-05-28 | 16:01 ET | [8-K](/filings/0001193125-26-245164.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-245164 |
| 2026-05-15 | 08:30 ET | [8-K](/filings/0001193125-26-225435.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-225435 |
| 2026-05-12 | 16:07 ET | [8-K](/filings/0001193125-26-219400.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-219400 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000030625-26-000003.md), filed Feb 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/dbbdd713-dab2-4426-9e44-cf695c848ed4)

## About the filer

- CIK: 30625
- Tickers: FLS
- Exchange: NYSE
- SIC code: 3561 Pumps & Pumping Equipment
- State of incorporation: NY
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:12 ET. No prices; not investment advice.
